NovaBridge Biosciences Current Liabilities
NovaBridge Biosciences (NBP) had Current Liabilities of $26.89 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-04-07
- 2023-12-31: Liabilities, Current 411.81M CNY.
- 2022-12-31: Liabilities, Current 758.17M CNY.
- 2022-06-30: Liabilities, Current 590.00M CNY.
- 2021-12-31: Liabilities, Current 624.00M CNY.
CNY
| Period end | Liabilities, Current |
|---|---|
| 2023-12-31 | 411.81M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 758.17M CNY 20-F · filed 2024-04-30 |
| 2022-06-30 | 590.00M CNY 6-K · filed 2022-11-10 |
| 2021-12-31 | 624.00M CNY 20-F · filed 2023-05-01 |
| 2020-12-31 | 576.13M CNY 20-F · filed 2022-04-29 |
| 2020-09-30 | 349.40M CNY 6-K · filed 2021-02-05 |
| 2019-12-31 | 588.48M CNY 20-F · filed 2021-04-28 |
| 2018-12-31 | 346.16M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $26.89M 20-F · filed 2026-04-07 | |
| 2025-09-30 | $16.09M 6-K · filed 2025-12-18 | |
| 2025-06-30 | $7.35M 6-K · filed 2025-10-06 | |
| 2024-12-31 | $8.45M 20-F · filed 2026-04-07 | |
| 2023-12-31 | $58.14M 20-F · filed 2025-04-03 | $58.00M 20-F · filed 2024-04-30 |
| 2022-12-31 | $109.92M 20-F · filed 2023-05-01 | |
| 2022-06-30 | $88.08M 6-K · filed 2022-11-10 | |
| 2021-12-31 | $97.92M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $88.30M 20-F · filed 2021-04-28 | |
| 2020-09-30 | $51.46M 6-K · filed 2021-02-05 | |
| 2019-12-31 | $84.53M 20-F · filed 2020-04-29 |